Dr Cord Willhöft, LL.M. (KCL) > Fieldfisher > Munich, Germany > Lawyer Profile

Fieldfisher
18TH FLOOR CENTRAL TOWER
LANDSBERGER STR 110
80339 MUNICH
Germany

Work Department

Life Sciences Regulatory

Position

Dr Cord Willhöft, LL.M. (KCL) is a Partner in Fieldfisher’s Munich office and advises medical device manufacturers and pharmaceutical companies on sector-specific matters, in particular Regulatory, Healthcare Compliance and reimbursement in SHI.

His regulatory expertise covers the placing on the market of medical devices and medicinal products, including clinical evaluation and testing, conformity assessment procedures and authorisation, making available on the market, MDR compliance of economic operators, as well as the representation of companies’ interests vis-à-vis authorities and courts.

The area of Healthcare Compliance includes the legally compliant design of cooperation with healthcare professionals and patient organisations, as well as product-related sales promotion.

He is a leading expert in the area of SHI reimbursement of medical devices in the outpatient and inpatient service area of SHI.

In particular, we advise companies on medical device method assessment procedures (§ 137h SGB V) and testing procedures (§ 137e SGB V).

We have advised numerous (US) companies on the implementation of MDR requirements, including ZOLL Medical Co, Asahi Kasei Medical, Starkey, Galvanize Therapeutics, Pulmonx, Saluda Medical, Procept, Corvia Medical, Route 92, Intersect ENT and ResMed.

He gets recommandations from JUVE and Legal 500.

Languages

He advises his clients in German and English.

Memberships

He is a regular speaker, gives trainings in companies and is also involved in local sports clubs (Münchener Ruderclub von 1880).

Personal

He regularly publishes in relevant journals and is, among other things, co-author of the medical devices law commentary Lücker/Baumann.

Lawyer Rankings

Germany > Industry focus > Healthcare and life sciences

Fieldfisher advises pharmaceutical, biotechnology and medical technology companies, healthcare providers and medical technology start-ups on regulatory market entry for medical devices and pharmaceuticals, including related clinical trials, conformity assessment procedures and licensing issues, as well as on compliance and transactions. This mirrors the focus of practice head Cord Willhöft.